Dn B Asset Management As Pfizer Inc Transaction History

Dn B Asset Management As

$19.9 Billion
Q2 2024

A detailed history of Dn B Asset Management As transactions in Pfizer Inc stock. As of the latest transaction made, Dn B Asset Management As holds 1,444,525 shares of PFE stock, worth $41.3 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

1,444,525

Previous 1,361,372 6.11%

Holding current value

$41.3 Million

Previous $37.8 Million 6.99%

% of portfolio

0.2%

Previous 0.21%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	BUY	$25.26 - $29.6 $2.1 Million - $2.46 Million	83,153 Added 6.11%	1,444,525 $40.4 Million
Q1 2024 Apr 12, 2024	SELL	$25.89 - $29.73 $48.3 Million - $55.5 Million	-1,866,024 Reduced 57.82%	1,361,372 $37.8 Million
Q4 2023 Jan 04, 2024	BUY	$26.13 - $33.94 $4.02 Million - $5.22 Million	153,719 Added 5.0%	3,227,396 $92.9 Million
Q3 2023 Oct 13, 2023	BUY	$32.09 - $37.51 $4.45 Million - $5.2 Million	138,558 Added 4.72%	3,073,677 $102 Million
Q2 2023 Jul 06, 2023	BUY	$36.12 - $41.79 $1.97 Million - $2.27 Million	54,410 Added 1.89%	2,935,119 $108 Million
Q1 2023 Apr 20, 2023	BUY	$39.39 - $51.28 $1.34 Million - $1.75 Million	34,088 Added 1.2%	2,880,709 $118 Million
Q4 2022 Jan 12, 2023	BUY	$41.75 - $54.5 $617,190 - $805,673	14,783 Added 0.52%	2,846,621 $146 Billion
Q3 2022 Oct 11, 2022	SELL	$43.76 - $53.42 $1.34 Million - $1.63 Million	-30,579 Reduced 1.07%	2,831,838 $124 Million
Q2 2022 Jul 08, 2022	SELL	$46.53 - $55.17 $7.95 Million - $9.43 Million	-170,863 Reduced 5.63%	2,862,417 $150 Billion
Q1 2022 Apr 08, 2022	BUY	$45.75 - $56.69 $37.4 Million - $46.3 Million	817,416 Added 36.89%	3,033,280 $157 Million
Q4 2021 Jan 12, 2022	SELL	$41.32 - $61.25 $1.36 Million - $2.01 Million	-32,857 Reduced 1.46%	2,215,864 $131 Million
Q3 2021 Oct 15, 2021	SELL	$39.25 - $50.42 $954,206 - $1.23 Million	-24,311 Reduced 1.07%	2,248,721 $96.7 Million
Q2 2021 Jul 06, 2021	BUY	$35.91 - $40.68 $4.11 Million - $4.65 Million	114,370 Added 5.3%	2,273,032 $89 Billion
Q1 2021 Apr 15, 2021	SELL	$33.49 - $37.77 $44.6 Million - $50.3 Million	-1,330,821 Reduced 38.14%	2,158,662 $78.2 Million
Q4 2020 Jan 19, 2021	SELL	$33.47 - $42.56 $6.36 Million - $8.09 Million	-190,049 Reduced 5.17%	3,489,483 $128 Million
Q3 2020 Oct 14, 2020	SELL	$31.75 - $37.25 $17.3 Million - $20.3 Million	-546,117 Reduced 12.92%	3,679,532 $128 Million
Q2 2020 Jul 08, 2020	SELL	$30.12 - $36.54 $5.51 Million - $6.69 Million	-183,032 Reduced 4.15%	4,225,649 $138 Billion
Q1 2020 Apr 17, 2020	BUY	$27.03 - $38.62 $32.7 Million - $46.8 Million	1,211,174 Added 37.88%	4,408,681 $137 Million
Q4 2019 Jan 13, 2020	SELL	$32.92 - $37.36 $17.7 Million - $20 Million	-536,537 Reduced 14.37%	3,197,507 $119 Million
Q3 2019 Oct 16, 2019	BUY	$32.49 - $42.13 $85.7 Million - $111 Million	2,638,873 Added 240.96%	3,734,044 $127 Million
Q2 2019 Jul 08, 2019	BUY	$36.98 - $41.52 $741,485 - $832,517	20,051 Added 1.87%	1,095,171 $0
Q1 2019 Apr 11, 2019	SELL	$37.5 - $41.2 $3.45 Million - $3.79 Million	-91,959 Reduced 7.88%	1,075,120 $0
Q4 2018 Jan 15, 2019	SELL	$38.47 - $43.86 $6.78 Million - $7.73 Million	-176,248 Reduced 13.12%	1,167,079 $48.3 Million
Q3 2018 Oct 10, 2018	BUY	$34.47 - $41.81 $4.03 Million - $4.89 Million	116,987 Added 9.54%	1,343,327 $0
Q2 2018 Jul 06, 2018	BUY	$32.98 - $35.16 $2.32 Million - $2.47 Million	70,200 Added 6.07%	1,226,340 $0
Q1 2018 Apr 11, 2018	BUY	$31.91 - $37.02 $8.45 Million - $9.81 Million	264,900 Added 29.72%	1,156,140 $0
Q4 2017 Jan 10, 2018	BUY	$33.26 - $35.29 $9.09 Million - $9.65 Million	273,339 Added 44.24%	891,240 $0
Q3 2017 Oct 11, 2017	BUY	$31.0 - $34.15 $19.2 Million - $21.1 Million	617,901	617,901 $0

Others Institutions Holding PFE

# of Institutions

3,216

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Account

Dn B Asset Management As Pfizer Inc Transaction History